Shares in Ocular Therapeutix (NSDQ:OCUL) fell in premarket activity today after the company posted mixed fourth-quarter results.
The Bedford, Mass.-based company posted a net loss of -$17.4 million, or -42¢ per share, on sales of $504,000 for the three months ended Dec. 31, for sales growth of 3.5% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Ocular Therapeutix posts mixed Q4 results appeared first on MassDevice.
from MassDevice https://ift.tt/2HlS6yj
Cap comentari:
Publica un comentari a l'entrada